Translating CD47-targeted therapy in gastrointestinal cancers: Insights from preclinical to clinical studies
Summary: This review presents a thorough investigation of the role of CD47 in gastrointestinal cancers. We performed a comprehensive, in-depth review of over 100 preclinical and clinical studies focused on inhibiting CD47. The research highlights the potential of targeted CD47 to enhance existing tr...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | iScience |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004224027056 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846113040427122688 |
|---|---|
| author | Changgan Chen Fengchun Lu Heguang Huang Yu Pan |
| author_facet | Changgan Chen Fengchun Lu Heguang Huang Yu Pan |
| author_sort | Changgan Chen |
| collection | DOAJ |
| description | Summary: This review presents a thorough investigation of the role of CD47 in gastrointestinal cancers. We performed a comprehensive, in-depth review of over 100 preclinical and clinical studies focused on inhibiting CD47. The research highlights the potential of targeted CD47 to enhance existing treatments by boosting the immune response to cancer cells. Considering the essential need to balance the toxicity and efficacy of CD47 inhibition, our review emphasizes the need to optimize CD47 inhibitors. We also demonstrate the necessity of combining CD47 antibodies with conventional chemotherapy, radiotherapy, or other targeted therapies to enhance treatment effectiveness. Finally, we propose the integration of CD47-targeted therapies into treatment plans as a promising approach to reshape the therapeutic landscape of gastrointestinal cancers. Continued research in this field holds great potential for improving the outcomes of gastrointestinal cancer patients and overcoming the challenges associated with this formidable spectrum of diseases. |
| format | Article |
| id | doaj-art-051dbaee95bd475087f981eb808c8a5f |
| institution | Kabale University |
| issn | 2589-0042 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | iScience |
| spelling | doaj-art-051dbaee95bd475087f981eb808c8a5f2024-12-22T05:29:29ZengElsevieriScience2589-00422024-12-012712111478Translating CD47-targeted therapy in gastrointestinal cancers: Insights from preclinical to clinical studiesChanggan Chen0Fengchun Lu1Heguang Huang2Yu Pan3Department of General Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Fuzhou 350001, People's Republic of ChinaDepartment of General Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Fuzhou 350001, People's Republic of ChinaDepartment of General Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Fuzhou 350001, People's Republic of China; Corresponding authorDepartment of General Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Fuzhou 350001, People's Republic of China; The Cancer Center, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China; Corresponding authorSummary: This review presents a thorough investigation of the role of CD47 in gastrointestinal cancers. We performed a comprehensive, in-depth review of over 100 preclinical and clinical studies focused on inhibiting CD47. The research highlights the potential of targeted CD47 to enhance existing treatments by boosting the immune response to cancer cells. Considering the essential need to balance the toxicity and efficacy of CD47 inhibition, our review emphasizes the need to optimize CD47 inhibitors. We also demonstrate the necessity of combining CD47 antibodies with conventional chemotherapy, radiotherapy, or other targeted therapies to enhance treatment effectiveness. Finally, we propose the integration of CD47-targeted therapies into treatment plans as a promising approach to reshape the therapeutic landscape of gastrointestinal cancers. Continued research in this field holds great potential for improving the outcomes of gastrointestinal cancer patients and overcoming the challenges associated with this formidable spectrum of diseases.http://www.sciencedirect.com/science/article/pii/S2589004224027056Health sciencesImmunologyInternal medicineMedical specialtyMedicineNatural sciences |
| spellingShingle | Changgan Chen Fengchun Lu Heguang Huang Yu Pan Translating CD47-targeted therapy in gastrointestinal cancers: Insights from preclinical to clinical studies iScience Health sciences Immunology Internal medicine Medical specialty Medicine Natural sciences |
| title | Translating CD47-targeted therapy in gastrointestinal cancers: Insights from preclinical to clinical studies |
| title_full | Translating CD47-targeted therapy in gastrointestinal cancers: Insights from preclinical to clinical studies |
| title_fullStr | Translating CD47-targeted therapy in gastrointestinal cancers: Insights from preclinical to clinical studies |
| title_full_unstemmed | Translating CD47-targeted therapy in gastrointestinal cancers: Insights from preclinical to clinical studies |
| title_short | Translating CD47-targeted therapy in gastrointestinal cancers: Insights from preclinical to clinical studies |
| title_sort | translating cd47 targeted therapy in gastrointestinal cancers insights from preclinical to clinical studies |
| topic | Health sciences Immunology Internal medicine Medical specialty Medicine Natural sciences |
| url | http://www.sciencedirect.com/science/article/pii/S2589004224027056 |
| work_keys_str_mv | AT changganchen translatingcd47targetedtherapyingastrointestinalcancersinsightsfrompreclinicaltoclinicalstudies AT fengchunlu translatingcd47targetedtherapyingastrointestinalcancersinsightsfrompreclinicaltoclinicalstudies AT heguanghuang translatingcd47targetedtherapyingastrointestinalcancersinsightsfrompreclinicaltoclinicalstudies AT yupan translatingcd47targetedtherapyingastrointestinalcancersinsightsfrompreclinicaltoclinicalstudies |